Geode Capital Management’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.86M | Sell |
749,484
-57,996
|
|
||||
|
2025
Q1 | $2.12M | Buy |
807,480
+56,987
|
|
||||
|
2024
Q4 | $2.66M | Buy |
750,493
+107,151
|
|
||||
|
2024
Q3 | $2.93M | Buy |
643,342
+61,582
|
|
||||
|
2024
Q2 | $2.53M | Buy |
581,760
+39,917
|
|
||||
|
2024
Q1 | $2.72M | Buy |
541,843
+4,095
|
|
||||
|
2023
Q4 | $3.37M | Buy |
537,748
+25,927
|
|
||||
|
2023
Q3 | $3.64M | Buy |
511,821
+66,107
|
|
||||
|
2023
Q2 | $4.54M | Buy |
445,714
+274,270
|
|
||||
|
2023
Q1 | $1.55M | Buy |
171,444
+74,523
|
|
||||
|
2022
Q4 | $694K | Buy |
96,921
+11,736
|
|
||||
|
2022
Q3 | $555K | Buy |
85,185
+6,611
|
|
||||
|
2022
Q2 | $378K | Buy |
78,574
+9,322
|
|
||||
|
2022
Q1 | $393K | Sell |
69,252
-1,957
|
|
||||
|
2021
Q4 | $357K | Sell |
71,209
-14
|
|
||||
|
2021
Q3 | $473K | Buy |
71,223
+4,748
|
|
||||
|
2021
Q2 | $406K | Sell |
66,475
-31,605
|
|
||||
|
2021
Q1 | $652K | Buy |
98,080
+6,560
|
|
||||
|
2020
Q4 | $484K | Buy |
91,520
+6,273
|
|
||||
|
2020
Q3 | $635K | Buy |
85,247
+9,995
|
|
||||
|
2020
Q2 | $553K | Buy |
75,252
+44,224
|
|
||||
|
2020
Q1 | $229K | Hold |
31,028
|
|
||||
|
2019
Q4 | $175K | Sell |
31,028
-1,655
|
|
||||
|
2019
Q3 | $193K | Hold |
32,683
|
|
||||
|
2019
Q2 | $104K | Sell |
32,683
-22,360
|
|
||||
|
2019
Q1 | $165K | Buy |
55,043
+3,123
|
|
||||
|
2018
Q4 | $195K | Buy |
51,920
+1,635
|
|
||||
|
2018
Q3 | $295K | Buy |
50,285
+3,484
|
|
||||
|
2018
Q2 | $264K | Buy |
46,801
+6,353
|
|
||||
|
2018
Q1 | $501K | Buy |
+40,448
|
|